Overview

Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting

Status:
COMPLETED

Trial end date:
2024-06-05

Target enrollment:

Participant gender:

Summary

The goal of this Interventional study is to evaluate the efficacy and safety of Aprepitant Injection(QLG2174) for preventing PONV in Chinese patients.

Phase:

PHASE3

Details

Lead Sponsor:

Qilu Pharmaceutical (Hainan) Co., Ltd.

Treatments:

Aprepitant